{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:57:17Z","timestamp":1777953437728,"version":"3.51.4"},"reference-count":0,"publisher":"Oncology Nursing Society (ONS)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1188\/26.onf.e26535303","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:15:07Z","timestamp":1777907707000},"source":"Crossref","is-referenced-by-count":0,"title":["Symptom Burden of Immune Checkpoint Inhibitor Therapy: Development of a Patient-Reported Outcome Measure"],"prefix":"10.1188","member":"1302","published-online":{"date-parts":[[2026,5,4]]},"container-title":["Oncology Nursing Forum"],"original-title":[],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T15:15:07Z","timestamp":1777907707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/53\/3\/symptom-burden-immune-checkpoint-inhibitor-therapy-development"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1188\/26.onf.e26535303","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"article-number":"e26535303"}}